Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Atherectomy Devices Market, by Type
1.4.2 North America Atherectomy Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Atherectomy Devices Market by Type
3.1 North America Directional Atherectomy Market by Country
3.2 North America Rotational Atherectomy Market by Country
3.3 North America Orbital Atherectomy Market by Country
3.4 North America Laser Atherectomy Market by Country
Chapter 4. North America Atherectomy Devices Market by Country
4.1 USA Atherectomy Devices Market
4.1.1 USA Atherectomy Devices Market by Type
4.2 Canada Atherectomy Devices Market
4.2.1 Canada Atherectomy Devices Market by Type
4.3 Mexico Atherectomy Devices Market
4.3.1 Mexico Atherectomy Devices Market by Type
4.4 Rest of North America Atherectomy Devices Market
4.4.1 Rest of North America Atherectomy Devices Market by Type
Chapter 5. Company Profiles
5.1 Cardiovascular Systems, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.1.5 Recent strategies and developments:
5.1.5.1 Collaborations, partnerships and agreements:
5.1.5.2 Acquisition and mergers:
5.2 Avinger, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Product launches:
5.2.1.2 Approval:
5.3 Straub Medical AG
5.3.1 Company Overview
5.4 Boston Scientific Corporation
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent strategies and developments:
5.4.5.1 Acquisition and mergers:
5.5 Medtronic PLC (Covidien)
5.5.1 Company overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.5.5 Recent strategies and developments:
5.5.5.1 Acquisition and mergers:
5.5.5.2 Approval:
5.6 Koninklijke Philips N.V.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expenses
5.6.5 Recent strategies and developments:
5.6.5.1 Acquisition and mergers:
5.7 Cardinal Health, Inc. (Cordis)
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Segmental and Regional Analysis
5.8 Terumo Corporation (Terumo IS)
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.8.4 Recent strategies and developments:
5.8.4.1 Acquisition and mergers:
5.8.4.2 Expansions:
5.9 Abbott Laboratories
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental and Regional Analysis
5.9.4 Research & Development Expense
5.9.5 Recent strategies and developments:
5.9.5.1 Acquisition and mergers:
5.1 B. Braun Melsungen AG
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
5.10.4 Research & Development Expense
Unique Offerings 
